Contraceptives are also known as fertility control which is a drug that prevents pregnancy. The most effective methods of birth control are sterilization using vasectomy in males and tubal ligation in females, intrauterine devices, and implantable birth control. Contraceptive drugs are of three types of oral contraceptives, injectable contraceptives and topical contraceptives.

Global Contraceptives Market Size & Growth:

The global contraceptives market is estimated to reach at $38.14 Billion by 2025 at a CAGR of 6.8% from $25.70 Billion in 2019 during 2019-2025. The significant factors responsible for the growth are a rise in awareness of modern contraception, cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies, and growing incidence of the sexually transmitted diseases (STDs). Also, favourable regulatory scenario and awareness programs, effective contraception, fewer side effects of IUCDs and conceivable non-contraception health benefits are also contributing to the market growth.

Health risks associated with the use of contraceptive methods, religious and cultural opposition towards contraceptive methods, stringent regulations and reimbursement policies, lack of awareness and constrained access in developing economies are major restraints hindering the growth of the market. The rise in disposable income and demand for healthy life and presence of large unmet contraceptive needs in emerging Asian and African economies are creating major opportunities to the contraceptives market during the forecast period 2019-2025

Global Contraceptives Market Segments Share:

The global contraceptives market is segmented based on the product, age group, education, distribution channel, end user and geography. By product, the market is classified into contraceptive drugs and contraceptive devices. Contraceptive drugs are further categorized into oral (pills), injectable, and topical contraceptives. The oral contraceptives hold the largest market share in the contraceptives market is owing to the widespread use of oral pills by women because they are proven to be highly effective up to 99% in preventing pregnancy. Contraceptive devices are categorized into condoms, IUDs, diaphragms, sponges, patches, implants, and vaginal rings. Among these, condoms hold the largest market share, and IUD’s are expected to grow faster pace during the forecast period 2019-2025. By age group, the market is categorized into 15-24, 25-34, 35-44, and above 44.

By education, the global contraceptives market is segregated into less than high school, high school graduate, college graduate and others. By distribution channel, hospital pharmacy, independent pharmacy and online platforms. Independent pharmacy segment is expected to register highest CAGR in global contraceptives market due to cumulative government initiatives and private firms to prevent unwanted abortions and pregnancies. Hospital pharmacies hold largest market share in global contraceptives market due to effective contraception and fewer side effects of IUCDs and conceivable non-contraception health benefits.

By end user, the global contraceptives market is classified into households, clinics and hospitals. Among these, household segment holds the largest market share in the global contraceptives market due to widespread consumption of oral pills and condoms to prevent unintended pregnancy and STI’s. Hospitals segment is estimated to register the highest growth in the global contraceptives market due to effective contraception and fewer side effects of IUCD’s.

By geography, the global contraceptives market is segmented into North America, South America, Asia Pacific, Europe, Middle East and Africa. North America region holds the largest market share in the global contraceptives market due to the presence of sophisticated healthcare facilities and the growing demand for contraceptives for preventing unwanted pregnancies, and favourable regulatory scenario. Asia Pacific is estimated to register highest CAGR in global contraceptives market due to rising prevalence of STDs, increasing awareness campaigns to raise awareness about contraceptives and several government initiatives.

Global Contraceptives Market Trends:

• Virginia launches $6 Million contraceptives initiative, and it will be rewarded to one dozen qualified healthcare providers to provide LARC’s to patients.
• September 2018. New fertility control pills containing both lower doses of oestrogens and newer progestogens which reduces the risk of ovarian cancer.

Global Contraceptives Market Research Report:

An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.

To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.

Regional and Global Diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year

Identifying DROC in the current market and their impact in altering the market dynamics.

Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial analysis with significant competitors.

Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.

The primary critical players in the global contraceptives market are:

• Bayer Healthcare Pharmaceuticals
• Actavis, Inc.
• Cooper Surgical, Inc.
• The Female Health Company
• Merck & Co., Inc.

Along with these companies, there were many other companies considered/ cited in the report while analysing the global contraceptives market. These companies hold substantial share-owning to the nature of the industry whereas the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players have considerable presence owing to its robust brand image, geographical reach and strong customer base.